SAN FRANCISCO--(BUSINESS WIRE)--Nile Therapeutics, Inc. (NASDAQ:NLTX), a biopharmaceutical company in the development of novel therapeutics for heart failure patients, today announced its fourth quarter and full year financial results for 2009. The company will host a conference call and live webcast to discuss these financial results and provide an update on each of its development programs at 8:30 a.m. EST on March 5, 2010. Interested investors may participate in the conference call by dialing +1-877-303-6918 (USA) or +1-973-638-3210 (international). Participants may also access both the live and archived webcast of the conference call from the homepage and the investor relations section of Nile’s website at www.nilethera.com.
